http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5939316-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd47318319f20f7f99d9fef1fd3e511b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
| filingDate | 1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1999-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fc60f4cbfb2b12ec66f8013721279c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_628e9008da46dd8d66eb69a8567b2da4 |
| publicationDate | 1999-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5939316-A |
| titleOfInvention | Chromosome 18 marker |
| abstract | The present invention relates to the mammalian fsh22 gene, a novel gene associated with bipolar affective disorder (BAD) in humans. The invention encompasses fsh22 nucleic acids, recombinant DNA molecules, cloned genes or degenerate variants thereof, fsh22 gene products and antibodies directed against such gene products, cloning vectors containing mammalian fsh22 gene molecules, and hosts that have been genetically engineered to express such molecules. The invention further relates to methods for the identification of compounds that modulate the expression of fsh22 and to using such compounds as therapeutic agents in the treatment of fsh22 disorders and neuropsychiatric disorders. The invention also relates to methods for the diagnostic evaluation, genetic testing and prognosis of fsh22 disorders and neuropsychiatric disorders including schizophrenia, attention deficit disorder, a schizoaffective disorder, a bipolar affective disorder or a unipolar affective disorder, and to methods and compositions for the treatment these disorders. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064401-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005059079-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6414131-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010003673-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002168675-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7101666-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6831153-B2 |
| priorityDate | 1997-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 712.